AEON Biopharma AEON
NYSE AEON
$0.18 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

AEON Biopharma (AEON) EV to EBIT (2024 - 2025)

Updated

AEON Biopharma's EV to EBIT came in at -0.06 for Q1 2025.

Analysis

AEON Biopharma (AEON) EV to EBIT (2024 - 2025) Analysis & Trends

Over the trailing twelve months to Mar 31, 2025, AEON Biopharma reported EV to EBIT of -0.08; for FY2024, it came in at 0.29.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 AEON Biopharma 9.26 Mn -9.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -0.06
Dec 31, 2024 0.29
API Access

AEON Biopharma EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AEON&period=max&api_key=YOUR_API_KEY